Efficacy and Safety of SYSA1902 Versus Reference Ustekinumab in Moderate-to-severe Plaque Psoriasis: A Multicenter, Randomized, Phase III Study.
Journal of the American Academy of Dermatology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of the American Academy of Dermatology(2025)